Medical News

RSS

Cipher completes enrolment in CIP-ISOTRETINOIN Phase III study for severe, nodular acne

Cipher Pharmaceuticals Inc. today announced that it has completed patient enrolment in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. The Phase III safety study is being conducted under a Special Protocol Assessment that was granted by the U.S. Food and Drug Administration (FDA).

29 Oct 2010

MannKind third quarter operating expenses decreases from $42.8 million to $42.5 million

MannKind Corporation today reported financial results for the third quarter ended September 30, 2010.

29 Oct 2010

North American children may be 'too clean'

Rising levels of allergic asthma and eczema in North American children have Canadian scientists wondering if there is such a thing as being "too clean." "We see auto-immune diseases like asthma and eczema increasing rapidly in North American children, but we don't see the same effect in children in the developing world," says Dr. B. Brett Finlay, a Professor in the Michael Smith Laboratories at the University of British Columbia.

29 Oct 2010

New Chicago Sports Concussion Clinic at Rush University provides proper diagnosis for athletes

Concussions, like any injury, need proper assessment and time to heal. Some may brush off an injury to the head, but an injury to the brain may be severe with possible long-term consequences. Athletes or individuals who suffer a bump or blow to the head now can see a physician for assessment within 24 to 48 hours at the new Chicago Sports Concussion Clinic at Rush University Medical Center.

29 Oct 2010

Scientists study infant-mother interactions to unveil mysteries about human cognitive development

To help unravel the mysteries of human cognitive development and reach new the frontiers in robotics, University of Miami (UM) developmental psychologists and computer scientists from the University of California in San Diego (UC San Diego) are studying infant-mother interactions and working to implement their findings in a baby robot capable of learning social skills.

29 Oct 2010

FDA awards 84 grants worth $18.5 million to boost food and feed safety initiatives

The U.S. Food and Drug Administration awarded 84 grants worth $18.5 million in fiscal year 2010 to help state and local regulatory agencies defend against and respond quickly to threats to the food supply and to outbreaks of foodborne diseases.

29 Oct 2010

ACRO responds to government report on FDA's Overseas Offices

The Association of Clinical Research Organizations, which represents the global CRO industry, issued the following statement in response to the Government Accountability Office's report on the Food and Drug Administration's Overseas Offices.

29 Oct 2010

Beryl Institute releases White Paper on patient experience

The Beryl Institute released its latest White Paper, The Four Cornerstones of an Exceptional Patient Experience, focusing on two newly released studies on the importance of the patient experience and describing the necessary ingredients of a successful service culture.

29 Oct 2010

We can consciously control neurons inside our head

Every day our brains are flooded by stimulation - sounds, sights and smells. At the same time, we are constantly engaged in an inner dialogue, ruminating about the past, musing about the future. Somehow the brain filters all this input instantly, selecting some things for long- or short-term storage, discarding others and focusing in on what's most important at any given instant.

29 Oct 2010

Mathematical models and maps to eliminate malaria

Two University of Florida researchers and their international colleagues have used mathematical models and maps to estimate the feasibility of eliminating malaria from countries that have the deadliest form of the disease.

29 Oct 2010

MAP Pharmaceuticals to present FREEDOM-301 Phase 3 trial data for migraine at EHMTIC Congress

MAP Pharmaceuticals, Inc. today announced new data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX orally inhaled migraine therapy showing low recurrence rates with LEVADEX. Eight additional analyses from the LEVADEX program also will be presented during the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.

29 Oct 2010

Merck reports $342 million net income for 2010 third quarter

Merck & Co., Inc. today announced financial results for the third quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.85, which excludes purchase accounting adjustments, restructuring costs, merger-related expenses and a $950 million legal reserve.

29 Oct 2010

Life Technologies and BGI partner to offer whole human genome resequencing on SOLiD™ 4 System

Life Technologies Corporation and BGI (formerly Beijing Genomics Institute) announced today that they have partnered to offer whole human genome resequencing on the SOLiD™ 4 System. BGI, one of the world's largest genomic centers, has acquired 27 SOLiD 4 Systems, which will allow BGI to deliver 50 whole human genome sequences a month.

29 Oct 2010

BioClinica enters five-year enterprise-wide agreement for Optimizer technology

BioClinica, Inc., a global provider of clinical trial management services, today announced that a Top Ten pharmaceutical company has entered into a five-year enterprise-wide agreement for BioClinica Optimizer to simulate and forecast clinical trial supply scenarios for their worldwide clinical trial operations.

From Clario 29 Oct 2010

Compugen signs oncology research collaboration agreement with Seattle Genetics

Compugen Ltd. announced today that it has signed a research collaboration agreement with Seattle Genetics, Inc., USA, covering a Compugen-discovered oncology target. The agreement provides Seattle Genetics with an initial evaluation period and an option for an exclusive worldwide milestone and royalty bearing license for development and commercialization of monoclonal antibody therapeutics addressing this novel target.

29 Oct 2010

Henry Schein third quarter net sales increases 14.1% to $1.9 billion

Henry Schein, Inc. the largest provider of healthcare products and services to office-based practitioners, today reported record financial results for the quarter ended September 25, 2010.

29 Oct 2010

LifePoint Hospitals third quarter revenues increase 11.7% to $832.3 million

LifePoint Hospitals, Inc. today announced results for the third quarter and nine months ended September 30, 2010.

29 Oct 2010

Study suggests microRNA binding site helps improved prognosis of colorectal cancer at early stage

A variant site linked to poor outcome in advanced colorectal cancer has now been found to predict improved prognosis in early stages of cancer, according to research presented at the American Association for Cancer Research special conference on Colorectal Cancer: Biology to Therapy, held Oct. 27-30, 2010.

29 Oct 2010

Dental health affects control of diabetes

Diabetes is a disease that affects every part of the body, and for people with unstable blood glucose levels there is a higher risk than normal for developing serious complications from poor oral hygiene. In a study by dLife, the world's largest diabetes community, and SoundView Research, Inc., 66 percent of active diabetes managers had not changed their oral care habits since being diagnosed and over half have not been advised by their dentist to take extra care to brush, floss, or rinse daily.

29 Oct 2010

Professionals share ideas on effective ways to educate patients, practitioners and public about cancer

Florence Nightingale once said that apprehension, uncertainty, waiting, expectation and fear of surprise do a patient more harm than any exertion. This valuable philosophy is shared by today's nurses, social workers and other healthcare professionals as they work to educate every patient -- before, during and after their treatment, leaving no question unanswered.

29 Oct 2010

Medical News

Cipher completes enrolment in CIP-ISOTRETINOIN Phase III study for severe, nodular acne

MannKind third quarter operating expenses decreases from $42.8 million to $42.5 million

North American children may be 'too clean'

New Chicago Sports Concussion Clinic at Rush University provides proper diagnosis for athletes

Scientists study infant-mother interactions to unveil mysteries about human cognitive development

FDA awards 84 grants worth $18.5 million to boost food and feed safety initiatives

ACRO responds to government report on FDA's Overseas Offices

Beryl Institute releases White Paper on patient experience

We can consciously control neurons inside our head

Mathematical models and maps to eliminate malaria

MAP Pharmaceuticals to present FREEDOM-301 Phase 3 trial data for migraine at EHMTIC Congress

Merck reports $342 million net income for 2010 third quarter

Life Technologies and BGI partner to offer whole human genome resequencing on SOLiD™ 4 System

BioClinica enters five-year enterprise-wide agreement for Optimizer technology

Compugen signs oncology research collaboration agreement with Seattle Genetics

Henry Schein third quarter net sales increases 14.1% to $1.9 billion

LifePoint Hospitals third quarter revenues increase 11.7% to $832.3 million

Study suggests microRNA binding site helps improved prognosis of colorectal cancer at early stage

Dental health affects control of diabetes

Professionals share ideas on effective ways to educate patients, practitioners and public about cancer

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News